下调会通过减少能源利用来增加细胞内脂质
Grazia Pennisi1, Samantha Maurotti2, Ester Ciociola3
1Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Italy (G.P., S.P.).
Arteriosclerosis, thrombosis, and vascular biology
|February 22, 2024
概括
使用沉默RNA降低血管类蛋白3 (ANGPTL3) 的细胞内下调,增加肝脏甘油三. 这是由于能源利用率降低而发生的,模仿肝细胞甲状腺功能低下.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 血管蛋白样蛋白3 (ANGPTL3) 对于脂蛋白平衡至关重要.
- 针对ANGPTL3的单克隆抗体在某些遗传条件下有效降低脂蛋白.
- 之前试图通过反感性寡核酸减少肝脏ANGPTL3合成,导致肝脏不良影响.
研究的目的:
- 研究 ANGPTL3 下调对肝细胞脂质含量的细胞内影响.
- 确定降低ANGPTL3合成是否会导致肝细胞内中性脂质的初级增加.
主要方法:
- 在各种人类肝细胞模型中,沉默RNA被用于降低ANGPTL3表达的调节.
- 实验包括2D细胞培养 (HepG2,Hep3B2,Huh7) 和3D球体 (人类初级肝细胞,HepG2/LX-2).
主要成果:
- 在所有测试模型中,ANGPTL3下调始终增加了细胞内中性脂质.
- 一个显著的发现是降低了1型二氧化酶蛋白水平,损害了β-氧化.
- 这种损伤导致肝脏脂质滴中的甘油三积累增加.
结论:
- 通过RNA干扰进行细胞内ANGPTL3沉默,导致肝细胞中的甘油三含量升高.
- 该机制涉及能源基质利用率降低,导致类似于细胞内肝细胞甲状腺功能低下的状态.
- 这些发现突出了与影响细胞内合成的ANGPTL3向疗法相关的潜在风险.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Overview of Lipid Metabolism
1.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


